HIV Pre-Exposure Prophylaxis Priming of Immune Effectors

Trial Profile

HIV Pre-Exposure Prophylaxis Priming of Immune Effectors

Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2017

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
  • Indications HIV-1 infections
  • Focus Biomarker; Pharmacodynamics
  • Acronyms PREPPIE
  • Most Recent Events

    • 18 Sep 2017 Status changed from not yet recruiting to recruiting.
    • 05 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top